Higher omega-3 index is associated with increased insulin sensitivity and more favourable metabolic profile in middle-aged overweight men

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Albert, Benjamin B ^a   Derraik, José G B ^a   Brennan, Christine M ^a   Biggs, Janene B ^a   Smith, Greg C ^b   Garg, Manohar L ^c   Cameron Smith, David ^a   Hofman, Paul L ^a,d   Cutfield, Wayne S ^a,d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ADULT; BLOOD PRESSURE; GENETICS; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; METABOLOME; METABOLOMICS; MIDDLE AGED; OBESITY;

ADULT; BLOOD PRESSURE; FATTY ACIDS, OMEGA-3; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; OVERWEIGHT;

EID: 84937508470     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06697     Document Type: Article

References (63)

1. De Fronzo, R. A. & Ferrannini, E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173-194 (1991).
2. Roger, V. L. et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123, e18-e209, doi:10.1161/CIR.0b013e3182009701 (2011).
3. Haroun, M. K. et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J. Am. Soc. Nephrol. 14, 2934-2941 (2003).
4. van Leiden, H. A. et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch. Ophthalmol. 121, 245-251 (2003).
5. Arcidiacono, B. et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp. Diabetes Res. 2012, 789174 (2012).
6. Goodpaster, B. H., Kelley, D. E., Wing, R. R., Meier, A. & Thaete, F. L. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48, 839-847, doi:10.2337/diabetes.48.4.839 (1999).
7. Kim, E. S. et al. Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth. Obesity 15, 3023-3030, doi:10.1038/oby.2007.360 (2007).
8. Villegas, R. et al. Fish, shellfish, and long-chain n23 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women. Am. J. Clin. Nutr. 94, 543-551, doi:10.3945/ajcn.111.013193 (2011).
9. Djoussé, L. et al. Plasma omega-3 fatty acids and incident diabetes in older adults. Am. J. Clin. Nutr. 94, 527-533, doi:10.3945/ajcn.111.013334 (2011).
10. Virtanen, J. K., Mursu, J., Voutilainen, S., Uusitupa, M. & Tuomainen, T. P. Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the Kuopio Ischemic Heart Disease Risk Factor study. Diabetes Care 37, 189-196, doi:10.2337/dc13-1504 (2014).
11. Oh, D. Y. et al. GPR120 is an omega-3 fatty acid receptor mediating potent antiinflammatory and insulin-sensitizing effects. Cell 142, 687-698, doi:10.1016/j.cell.2010.07.041 (2010).
12. Buettner, R. et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J. Mol. Endocrinol. 36, 485-501 (2006).
13. Ghafoorunissa, I. A., Rajkumar, L. & Acharya, V. Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J. Nutr. 135, 2634-2638 (2005).
14. Akinkuolie, A. O., Ngwa, J. S., Meigs, J. B. & Djousse, L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin. Nutr. 30, 702-707, doi:10.1016/j.clnu.2011.08.013 (2011).
15. López-Alarcón, M., Martínez-Coronado, A., Velarde-Castro, O., Rendón-Macías, E. & Fernández, J. Supplementation of n3 long-chain polyunsaturated fatty acid synergistically decreases insulin resistance with weight loss of obese prepubertal and pubertal children. Arch. Med. Res. 42, 502-508 (2011).
16. Ramel, A. et al. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 51, 1261-1268, doi:10.1007/s00125-008-1035-7 (2008).
17. Mori, T. A. et al. Dietary fish as amajor component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am. J. Clin. Nutr. 70, 817-825 (1999).
18. Esposito, K. et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA 292, 1440-1446 (2004).
19. Tsitouras, P., Gucciardo, F., Salbe, A., Heward, C. & Harman, S. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm. Metab. Res. 40, 199-205 (2008).
20. Vessby, B. et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 44, 312-319 (2001).
21. Harris, W. S. & Von Schacky, C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev. Med. 39, 212-220, doi:10.1016/j.ypmed.2004.02.030 (2004).
22. Matsuda, M. & De Fronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470 (1999).
23. Lorenzo, C., Haffner, S. M., Stancakova, A. & Laakso, M. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic Finnish offspring of type 2 diabetic individuals. J. Clin. Endocrinol. Metab. 95, 5082-5090 (2010).
24. Maki, K. C., Rains, T. M., Dicklin, M. R. & Bell, M. Repeatability of indices of insulin sensitivity and secretion from standard liquid meal tests in subjects with type 2 diabetes mellitus or normal or impaired fasting glucose. Diabetes Technol. Ther. 12, 895-900 (2010).
25. Kahn, S. et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42, 1663-1672 (1993).
26. Harris, W. S., Pottala, J. V., Sands, S. A. & Jones, P. G. Comparison of the effects of fish and fish-oil capsules on the n-3 fatty acid content of blood cells and plasma phospholipids. Am. J. Clin. Nutr. 86, 1621-1625 (2007).
27. Katan, M. B., Deslypere, J. P., van Birgelen, A. P., Penders, M. & Zegwaard, M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J. Lipid Res. 38, 2012-2022 (1997).
28. O'Brien, E. et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 320, 1128-1134 (2000).
29. Tardif, J. C., Lesage, F., Harel, F., Romeo, P. & Pressacco, J. Imaging biomarkers in atherosclerosis trials. Circ Cardiovasc Imaging 4, 319-333 (2011).
30. Casella, I. B. et al. A practical protocol to measure common carotid artery intimamedia thickness. Clinics 63, 515-520 (2008).
31. Hagstromer, M., Oja, P. & Sjostrom, M. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr. 9, 755-762 (2006).
32. Salmond, C., Crampton, P. & Atkinson, J. NZDep2006 Index of Deprivation. (Department of Public Health, University of Otago, Wellington, 2007).
33. Lepage, G. & Roy, C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 27, 114-120 (1986).
34. Dormann, C. F. et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography 36, 027-046 (2013).
35. Burrows, T., Collins, C. E. & Garg, M. L. Omega-3 index, obesity and insulin resistance in children. Int. J. Pediatr. Obes. 6, e532-539, doi:10.3109/17477166.2010.549489 (2011).
36. Boden, G. & Shulman, G. I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and b-cell dysfunction. Eur. J. Clin. Invest. 32, 14-23, doi:10.1046/j.1365-2362.32.s3.3.x (2002).
37. Hajer, G. R., van Haeften, T. W. & Visseren, F. L. J. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 29, 2959-2971, doi:10.1093/eurheartj/ehn387 (2008).
38. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
39. Tripathy, D. et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52, 2882-2887 (2003).
40. Neschen, S. et al. n-3 fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-α-dependent manner. Diabetes 56, 1034-1041, doi:10.2337/db06-1206 (2007).
41. Kalupahana, N. S., Claycombe, K. J. & Moustaid-Moussa, N. (n-3) fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv. Nutr. 2, 304-316, doi:10.3945/an.111.000505 (2011).
42. Bodles, A. M. et al. Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes. Am. J. Physiol. Endocrinol. Metab. 291, E1100-E1105 (2006).
43. Kahn, C. R., Chen, L. & Cohen, S. E. Unraveling the mechanism of action of thiazolidinediones. J. Clin. Invest. 106, 1305-1307, doi:10.1172/jci11705 (2000).
44. Im, D. S. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog. Lipid Res. 51, 232-237, doi:10.1016/j.plipres.2012.02.003 (2012).
45. Calder, P. C. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 91, 791-795, doi:10.1016/j.biochi.2009.01.008 (2009).
46. ORIGIN Trial Investigators et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycaemia. N. Engl. J. Med. 367, 309-318 (2012).
47. Montori, V. M., Farmer, A., Wollan, P. C. & Dinneen, S. F. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 23, 1407-1415 (2000).
48. Hartweg, J. et al. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 1, CD003205 (2008).
49. Utzschneider, K. M. et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32, 335-341 (2009).
50. Hara, T., Hirasawa, A., Ichimura, A., Kimura, I. & Tsujimoto, G. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J. Pharm. Sci. 100, 3594-3601 (2011).
51. Itoh, Y. et al. Free fatty acids regulate insulin secretion from pancreatic b-cells through GPR40. Nature 422, 173-176 (2003).
52. Morgan, N. G. & Dhayal, S. G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell. Biochem. Pharmacol. 78, 1419-1427 (2009).
53. Ohkubo, T. et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183-2189 (2002).
54. Geleijnse, J. M., Giltay, E. J., Grobbee, D. E., Donders, A. R. T. & Kok, F. J. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 20, 1493-1499 (2002).
55. Albert, C. M. et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346, 1113-1118, doi:10.1056/NEJMoa012918 (2002).
56. Pelikánová, T., Kohout, M., Válek, J. í., Baše, J. í. & Kazdová, L. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism. 38, 188-192 (1989).
57. Borkman, M. et al. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 328, 238-244 (1993).
58. Vessby, B., Tengblad, S. & Lithell, H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37, 1044-1050, doi:10.1007/bf00400468 (1994).
59. Abate, N., Garg, A., Peshock, R. M., Stray-Gundersen, J. & Grundy, S. M. Relationships of generalized and regional adiposity to insulin sensitivity in men. J. Clin. Invest. 96, 88-98, doi:10.1172/jci118083 (1995).
60. Micallef, M., Munro, I., Phang, M. & Garg, M. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br. J. Nutr. 102, 1370-1374, doi:10.1017/s0007114509382173 (2009).
61. Burrows, T., Collins, C. E. & Garg, M. L. Omega-3 index, obesity and insulin resistance in children. Int. J. Pediatr. Obes. 6, e532-e539, doi:doi:10.3109/17477166.2010.549489 (2011).
62. Buckley, J. D. & Howe, P. R. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes. Rev. 10, 648-659, doi:10.1111/j.1467-789X.2009.00584.x (2009).
63. Bender, N. et al. Fish or n3-PUFA intake and body composition: a systematic review and meta-analysis. Obes. Rev. 15, 657-665, doi:10.1111/obr.12189 (2014).